Universität Leipzig, Jahresbericht 2021
List of registered abstracts - Universität Leipzig
Antibody-Drug Conjugates as a Targeted Therapeutic Approach Across Entities in Oncology (12.05.2023)
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Contents – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Współpraca międzynarodowa uniwersytetów to większe możliwości
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo: Molecular Therapy - Nucleic Acids
IJMS | Free Full-Text | SATB1-Mediated Upregulation of the Oncogenic Receptor Tyrosine Kinase HER3 Antagonizes MET Inhibition in Gastric Cancer Cells
Cells | Free Full-Text | MicroRNA-30d-5p—A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Universität Leipzig, Jahresbericht 2021
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Schlusswort
Research
LPA receptor 1 (LPAR1) is a novel interaction partner of Filamin A that promotes Filamin A phosphorylation, MRTF-A transcriptional activity and oncogene-induced senescence | Oncogenesis
Research
list of registered abstracts (sorted by category) - Universität Leipzig
Aktuelles
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
